GlassScriptPrepare for your visit
Paramjit S Takhar
Family Medicine · Sacramento, CA · NPI 1184791048
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,574.34
in general payments reported to CMS, 2019-2025 · $1,303 in 2025
The $1,303 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $699.16
- Glaxosmithkline, LLC. $619.71
- Abbvie INC. $559.75
- Novo Nordisk INC $394.43
- Boehringer Ingelheim Pharmaceuticals, INC. $287.91
- Novartis Pharmaceuticals Corporation $243.06
Drugs and devices associated with these payments
Ozempic Rybelsus Ubrelvy Arexvy Shingrix Qulipta Kerendia Trelegy Ellipta Rexulti Breztri Farxiga Dexcom G6 Transmitter
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Paramjit Takhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/368578/paramjit-s-takhar